Search results for: 'China Cosmetics Market Analysis 2023'
- Related search terms
- analysis of the north american radiology image and information management systemnorth american radiology pacs and (ris(ris pacs) market
- analysis of the drug delivery devices market forecast to 2023
- analysis-of-top-30-features-of-mass-market-and-luxury-oems-in-northt-america
- market+size+of+china's+overseas+marketing+industry
- market 08 00 00 00
-
17 Apr 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Advanced Biologic Therapies, AI-powered Diagnostics, Drug Delivery Platforms, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping diagnostics, therapeutics, and clinical workflows across infectious diseases, women’s health, metabolic disorders, neurodegeneration, oncology, rare diseases, and musculoskeletal care. It hi...
$950.00 -
07 Sep 2026  |  Global  |  Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Technology Advancements, Clinical Progress, and Growth Opportunities in AI-Enabled Antibody Therapeutics
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion models, and structure-based models are expanding the u...
$4,950.00 -
19 Jun 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Driven Drug Discovery, Protein Engineering, Genomic Diagnostics, Advanced Drug Delivery, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and metabolic disorders, neuromuscular and neurodegenerative conditions, diabetes, ophthalmol...
$950.00 -
24 Jun 2026  |  Global  |  Market Research
Top 5 Growth Opportunities in AI-Enabled Drug Discovery, 2026
Growing Precision Medicine Research is Driving Agile Partnerships with Newer OoC Technologies
As the industry continues to innovate across novel small- and large-molecule therapies, including RNA-targeted small molecules, cell and gene therapies, and mRNA therapies, pharma sponsors increasingly rely on partners for technology access, database generation and analysis, and preclinical and clinical research.These disruptions continue to drive ...
$2,450.00 -
19 Feb 2025  |  Global  |  Market Research
Top 10 Strategic Imperatives in the Life Sciences Industry, 2025
Key Challenges, Trends, and Changes Transforming the Life Sciences Industry
Owing to constant developments and challenges in the life sciences industry, stakeholders must continue to be adaptable, innovative, and competitive to thrive. Industry leaders must reconsider their strategic positions annually by understanding the main forces behind the transformation, including potential, challenges, and drivers. This analysis e...
$2,450.00
Special Price $2,205.00 save 10 %
-
29 May 2024  |  Global  |  Technology Research
Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics)
Rising Popularity Among Tier 1 Pharma Companies and Technological Advances in Drug Delivery Push Biologics Development
There have been increasing incidences of rare ophthalmic diseases (e.g., retinitis pigmentosa, Stargardt disease, Leber congenital amaurosis) and prevalent diseases (e.g., age-related macular degeneration [AMD], geographic atrophy). While clinicians have used small molecules as the conventional therapeutic modality to manage these diseases, the urg...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Nov 2017  |  North America  |  Market Research
Global Biologics Market—Companies-to-Action
Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development
This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...
$3,000.00
Special Price $2,250.00 save 25 %
-
27 Sep 2017  |  Africa  |  Market Research
East African Pharmaceutical Market, Forecast to 2021
Generic Pharmaceutical Products Continue to Dominate with Increased Foreign Direct Investment by Asian Manufacturers
Pharmaceutical markets in Sub-Saharan Africa are experiencing rapid growth as governments and healthcare providers battle with their respective burdens of disease. The continent has one of the highest burdens of disease, such as HIV, malaria, and tuberculosis, yet has limited healthcare resources and spending. As such there are great opportunities ...
$4,950.00
Special Price $3,712.50 save 25 %
-
19 Aug 2025  |  Global  |  Market Research
Emerging Therapeutics for Neurodegenerative Diseases, Global, 2025-2030
Innovative Strategies Driving the Future of Neuro Diseases
This report is a thorough examination of the current and future face of therapy for neurodegenerative diseases, such as Alzheimer's and Parkinson's. It articulates important growth drivers (e.g., precision medicine, AI paradigm for diagnostics, and the transformational megatrends of aging populations) and barriers they will face (e.g., the nature o...
$4,950.00 -
07 Oct 2025  |  Global  |  Technology Research
Growth Opportunities in Radiopharmaceuticals
Emerging Interest from Big Pharma Players Is Pushing Industry Innovation Momentum
The report covers the clinical trial assessment for radiodiagnostics, including PET, SPECT, and radiopharmaceuticals, comprising Alpha therapy, Beta therapy, Auger Therapy, and Theranostics. The report covers the key players in each space and their contributions to the radiopharmaceuticals landscape.The report sheds light on technology innovations ...
$4,950.00